Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036341 (
schizophrenia
)
60,220
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the rodent forebrain GABAergic neurons are generated from progenitor cells that express the transcription factors Dlx1 and Dlx2. The Rap-1 guanine nucleotide exchange factor,
MR-GEF
, is turned on by many of these developing GABAergic neurons. Expression of both Dlx1/2 and
MR-GEF
is retained in both adult mouse and human forebrain where, in human, decreased Dlx1 expression has been associated with psychosis. Using in situ hybridization studies we show that
MR-GEF
expression is significantly down-regulated in the forebrain of Dlx1/2 double mutant mice suggesting that
MR-GEF
and Dlx1/2 form part of a common signalling pathway during GABAergic neuronal development. We therefore compared
MR-GEF
expression by in situ hybridization in individuals with major psychiatric disorders (
schizophrenia
, bipolar disorder, major depression) and control individuals. We observed a significant positive correlation between layers II and IV of the dorso-lateral prefrontal cortex (DLPFC) in the percentage of
MR-GEF
expressing neurons in individuals with bipolar disorder, but not in individuals with
schizophrenia
, major depressive disorder or in controls. Since
MR-GEF
encodes a Rap1 GEF able to activate G-protein signalling, we suggest that changes in
MR-GEF
expression could potentially influence neurotransmission.
...
PMID:Expression of the Rap1 guanine nucleotide exchange factor, MR-GEF, is altered in individuals with bipolar disorder. 2043 29